Sep 142012

BioCentury NewsMakers Biotech Industry ConferenceMembers of our investment banking team – Todd Wyche, Kevin Tyler and Rada Milenovici attended the BioCentury NewsMakers Conference in New York earlier this month. Also in attendance were members of our research team – Vernon Bernardino and Michael Higgins.

The conference featured companies with major product and earnings events that are expected to play key roles in the life sciences industry. And in the words of conference organizers, it’s “…the best opportunity — in a single day — for the investment and pharma business development communities to assess the prospects for biotech stocks and to compare notes with key members of the institutional investment and analyst communities and pharma business development executives.” We’re always pleased to take part.

If you were not able to connect with us at the conference, please reach out to us now.

Jul 192012

Strategic CFOs in the life sciences industry are increasingly employing ATMs because they enable companies to better control the financing process and the relatively low cost compared to more traditional follow-on financing vehicles.

Med City: Common Misunderstandings of an Emerging Financing Vehicle: At-the-Market Offerings

Mar 222012

Today we are announcing the initiation of research coverage of Akorn, Inc.(NASDAQ: AKRX), a company that develops, manufactures and markets multisource and branded pharmaceuticals. The report, issued by our analyst Michael Higgins, is the first one of the firm’s new equity research department, which was established in January.

Brinson Patrick Securities Initiates Research Coverage of Akorn, Inc.